tranylcypromine has been researched along with Alzheimer Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, KM; Hoe, HS; Jeon, H; Jeon, SG; Jeong, YH; Kim, YG; Lee, H; Lee, JS; Lee, YH; Lin, Y; Park, H; Park, JH | 1 |
| Belakavadi, M; Dell, J; Fondell, JD; Grover, GJ | 1 |
| Eisenhofer, G; Goldstein, DS; Keiser, HR; Kopin, IJ; Murphy, DL; Stull, R; Sunderland, T | 1 |
| Cohen, RM; Mueller, EA; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN | 1 |
| Jenike, MA | 1 |
1 trial(s) available for tranylcypromine and Alzheimer Disease
| Article | Year |
|---|---|
Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Female; Humans; Male; Middle Aged; Phenethylamines; Psychiatric Status Rating Scales; Selegiline; Tranylcypromine | 1988 |
4 other study(ies) available for tranylcypromine and Alzheimer Disease
| Article | Year |
|---|---|
The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Mice; Monoamine Oxidase Inhibitors; Tranylcypromine | 2020 |
Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events.
Topics: Acetylation; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cell Line, Tumor; Epigenesis, Genetic; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Male; Methylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Thyroid Hormone; Tranylcypromine; Triiodothyronine | 2011 |
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Topics: Alzheimer Disease; Animals; Catecholamines; Chromatography, Liquid; Depression; Dihydroxyphenylalanine; Dogs; Glycols; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Posture; Quality Control; Selegiline; Tranylcypromine | 1986 |
Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).
Topics: Age Factors; Aged; Alzheimer Disease; Depressive Disorder; Female; Humans; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Tranylcypromine | 1985 |